Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Mohammad Mehdi Ommat"'
Autor:
Mohammad Mehdi Ommati, Hanie Attari, Asma Siavashpour, Marzieh Shafaghat, Negar Azarpira, Hasti Ghaffari, Leila Moezi, Reza Heidari
Publikováno v:
Liver Research, Vol 5, Iss 3, Pp 181-193 (2021)
Background and aim: The liver is the primary organ affected by cholestasis, and complications such as renal injury, renal failure, and the need for renal transplantation are associated with cholestatic liver disease. There is substantial evidence ind
Externí odkaz:
https://doaj.org/article/5c111e6d175a497d8f0e234025f1b045
Autor:
Mohammad Mehdi Ommati, Hamidreza Mohammadi, Khadijeh Mousavi, Negar Azarpira, Omid Farshad, Reyhaneh Dehghani, Asma Najibi, Sedigheh Kamran, Hossein Niknahad, Reza Heidari
Publikováno v:
Liver Research, Vol 5, Iss 3, Pp 171-180 (2021)
Background and aim: Cholestasis-associated renal injury or cholemic nephropathy (CN) is a serious clinical problem. Previous studies mentioned that oxidative stress and mitochondrial impairment play a role in CN. There is no specific pharmacological
Externí odkaz:
https://doaj.org/article/fa5354ea490e42a8b2f51857bd5b1496
Autor:
Pouria Mobasher, Mohammad Mehdi Ommati, Asma Najibi, Amin Reza Akbarizadeh, Younes Ghasemi, Reza Heidari
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 7, Iss 3, Pp 179-190 (2021)
Mitochondria are cellular power plants known as essential organelles for energy (ATP) metabolism. However, today it is evident that various vital compounds are partially or exclusively synthesized in mitochondria. Moreover, this organelle plays a piv
Externí odkaz:
https://doaj.org/article/51672dcfa7d64e1fba997c836d266112
Autor:
Omid Farshad, Mohammad Mehdi Ommati, Jale Yüzügülen, Akram Jamshidzadeh, Khadijeh Mousavi, Zahra Ahmadi, Negar Azarpira, Hasti Ghaffari, Asma Najibi, Marzieh Shafaghat, Hossein Niknahad, Reza Heidari
Publikováno v:
Pharmaceutical Sciences, Vol 27, Iss 1, Pp 32-45 (2021)
Background: Cholestatic liver disease primarily affects hepatic tissue. Cholestasis could also influence the function of other organs rather than the liver. Cholestasis-induced kidney injury is a severe clinical complication known as "cholemic nephro
Externí odkaz:
https://doaj.org/article/4e0c9550ebe94292bccfd03b7b7723ea
Autor:
Hossein Niknahad, Mohammad Mehdi Ommati, Nazanin Sookhak, Farzaneh Hajihashemi, Negar Azarpira, Reza Heidari
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 7, Iss 1, Pp 59-72 (2021)
The liver injury could be induced in the association of a wide range of etiologies. Therefore, finding hepatoprotective agents with the potential clinical application has great value. Glycyrrhiza glabra (GG) is widely used in traditional medicine. Th
Externí odkaz:
https://doaj.org/article/fff3806becf642c08fcd06884611558d
Autor:
Omid Farshad, Mohammad Mehdi Ommati, Jale Yüzügülen, Sahand Alizadeh, Khadijeh Mousavi, Negar Azarpira, Anahita Marhonian, Akram Jamshidzadeh, Reza Heidari
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 6, Iss 3, Pp 189-204 (2020)
Cirrhosis-associated muscle mass loss or sarcopenia is a common complication (17-30% prevalence) in cirrhotic patients. However, the pathogenesis of this complication is poorly understood. Therefore, finding the mechanisms of sarcopenia could lead to
Externí odkaz:
https://doaj.org/article/eaa34ffd5bcd485b8d19376486244b31
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 6, Iss 2, Pp 73-86 (2020)
Different diseases or xenobiotics could cause cholestasis. The only promising treatment for this disease is the identification of its etiology or liver transplantation in severe cases. Nevertheless, preserving liver function could delay organ injury
Externí odkaz:
https://doaj.org/article/cb828e624abf43828897cb50ab0794dd
Publikováno v:
Trends in Pharmaceutical Sciences, Vol 6, Iss 2, Pp 87-96 (2020)
Surgery-associated small intestine damage is a clinical complication. It has been found that opening the abdominal cavity during surgery and manipulation of organs, including the intestine, could lead to intestinal barrier disintegrity and the entran
Externí odkaz:
https://doaj.org/article/b6a4bd9ddf0f41b994f240da41480f47
Autor:
Mohammad Mehdi Ommati, Omid Farshad, Hossein Niknahad, Khadijeh Mousavi, Marjan Moein, Negar Azarpira, Hamidreza Mohammadi, Akram Jamshidzadeh, Reza Heidari
Publikováno v:
Current Research in Pharmacology and Drug Discovery, Vol 1, Iss , Pp 10-18 (2020)
It has been well documented that cirrhosis is associated with the intestinal injury. Intestinal injury in cirrhosis could lead to bacterial lipopolysaccharide (LPS) translocation to the systemic circulation. It has been found that high plasma LPS is
Externí odkaz:
https://doaj.org/article/3838be379b3c4b74a87e5e0eafeb7dcf
Autor:
Narges Abdoli, Issa Sadeghian, Khadijeh Mousavi, Negar Azarpira, Mohammad Mehdi Ommati, Reza Heidari
Publikováno v:
Current Research in Pharmacology and Drug Discovery, Vol 1, Iss , Pp 30-38 (2020)
Cirrhosis-induced renal injury or cholemic nephropathy (CN) is a serious clinical complication with poor prognosis. CN could finally lead to renal failure and the need for organ transplantation. Unfortunately, there is no specific pharmacological int
Externí odkaz:
https://doaj.org/article/d5d52f00b9ae499d9040f39f3fb21668